Number of the records: 1  

Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem Study

  1. 1.
    Vrajová, M. - Šťastný, František - Horáček, J. - Lochman, J. - Šerý, O. - Peková, S. - Klaschka, Jan - Höschl, C.
    Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem Study.
    Neurochemical Research. Roč. 35, č. 7 (2010), s. 994-1002. ISSN 0364-3190
    Impact factor: 2.608, year: 2010
    http://hdl.handle.net/11104/0185943

    Cited: 27

    --- RUBIO, M.D. - DRUMMOND, J.B. - MEADOR-WOODRUFF, J.H. Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments. BIOMOLECULES & THERAPEUTICS. ISSN 1976-9148, JAN 31 2012, vol. 20, no. 1, p. 1-18. [WOS]
    --- STONE, W.S. - HSI, X.L. Declarative memory deficits and schizophrenia: Problems and prospects. NEUROBIOLOGY OF LEARNING AND MEMORY. ISSN 1074-7427, NOV 2011, vol. 96, no. 4, SI, p. 544-552. [WOS]
    --- SEGNITZ, N. - FERBERT, T. - SCHMITT, A. - GASS, P. - GEBICKE-HAERTER, P.J. - ZINK, M. Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain. PSYCHOPHARMACOLOGY. ISSN 0033-3158, SEP 2011, vol. 217, no. 1, p. 127-142. [WOS]
    --- GEDDES, A.E. - HUANG, X.F. - NEWELL, K.A. Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulinl and their role in schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. ISSN 0278-5846, JUN 1 2011, vol. 35, no. 4, p. 896-904. [WOS]
    --- GUILARTE, T.R. - OPLER, M. - PLETNIKOV, M. Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses. NEUROTOXICOLOGY. ISSN 0161-813X, JUN 2012, vol. 33, no. 3, p. 560-574. [WOS]
    --- KIM, K.C. - LEE, D.K. - GO, H.S. - KIM, P. - CHOI, C.S. - KIM, J.W. - JEON, S.J. - SONG, M.R. - SHIN, C.Y. Pax6-Dependent Cortical Glutamatergic Neuronal Differentiation Regulates Autism-Like Behavior in Prenatally Valproic Acid-Exposed Rat Offspring. MOLECULAR NEUROBIOLOGY. ISSN 0893-7648, FEB 2014, vol. 49, no. 1, p. 512-528. [WOS]
    --- ERRICO, F. - NAPOLITANO, F. - SQUILLACE, M. - VITUCCI, D. - BLASI, G. - DE BARTOLOMEIS, A. - BERTOLINO, A. - D'ANIELLO, A. - USIELLO, A. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia. JOURNAL OF PSYCHIATRIC RESEARCH. ISSN 0022-3956, OCT 2013, vol. 47, no. 10, p. 1432-1437. [WOS]
    --- BURT, M.A. - TSE, Y.C. - BOKSA, P. - WONG, T.P. Prenatal immune activation interacts with stress and corticosterone exposure later in life to modulate N-methyl-D-aspartate receptor synaptic function and plasticity. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. ISSN 1461-1457, SEP 2013, vol. 16, no. 8, p. 1835-1848. [WOS]
    --- CHAUDHARY, S. - KAUSHIK, M. - KUKRETI, R. - KUKRETI, S. Structural switch from a multistranded G-quadruplex to single strands as a consequence of point mutation in the promoter of the human GRIN1 gene. MOLECULAR BIOSYSTEMS. ISSN 1742-206X, SEP 1 2017, vol. 13, no. 9, p. 1805-1816. [WOS]
    --- CUMMINGS, K.A. - BELIN, S. - POPESCU, G.K. Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-D-aspartate receptors. NEUROPHARMACOLOGY. ISSN 0028-3908, JUN 2017, vol. 119, p. 40-47. [WOS]
    --- KALWEIT, A.N. - AMANPOUR-GHARAEI, B. - COLITTI-KLAUSNITZER, J. - MANAHAN-VAUGHAN, D. Changes in Neuronal Oscillations Accompany the Loss of Hippocampal LTP that Occurs in an Animal Model of Psychosis. FRONTIERS IN BEHAVIORAL NEUROSCIENCE. ISSN 1662-5153, MAR 8 2017, vol. 11. [WOS]
    --- ZHANG, Q. - LIU, Q. - LI, T.Z. - LIU, Y. - WANG, L. - ZHANG, Z.H. - LIU, H.Z. - HU, M. - QIAO, Y.H. - NIU, H.C. Expression and colocalization of NMDA receptor and FosB/Delta FosB in sensitive brain regions in rats after chronic morphine exposure. NEUROSCIENCE LETTERS. ISSN 0304-3940, FEB 12 2016, vol. 614, p. 70-76. [WOS]
    --- KRZYSTANEK, M. - BOGUS, K. - PALASZ, A. - WIADERKIEWICZ, A. - FILIPCZYK, L. - ROJCZYK, E. - WORTHINGTON, J. - WIADERKIEWICZ, R. Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon. PHARMACOLOGICAL REPORTS. ISSN 1734-1140, 2016, vol. 68, no. 5, p. 990-995. [WOS]
    --- KOTLAR, A.V. - MERCER, K.B. - ZWICK, M.E. - MULLE, J.G. New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. EUROPEAN JOURNAL OF MEDICAL GENETICS. ISSN 1769-7212, DEC 2015, vol. 58, no. 12, p. 704-714. [WOS]
    --- STRZELECKI, D. - PODGORSKI, M. - KALUZYNSKA, O. - GAWLIK-KOTELNICKA, O. - STEFANCZYK, L. - KOTLICKA-ANTCZAK, M. - GMITROWICZ, A. - GRZELAK, P. Supplementation of antipsychotic treatment with sarcosine-GlyT1 inhibitor - causes changes of glutamatergic (NMR)-N-1 spectroscopy parameters in the left hippocampus in patients with stable schizophrenia. NEUROSCIENCE LETTERS. ISSN 0304-3940, OCT 8 2015, vol. 606, p. 7-12. [WOS]
    --- MATOSIN, N. - FERNANDEZ-ENRIGHT, F. - LUM, J.S. - ANDREWS, J.L. - ENGEL, M. - HUANG, X.F. - NEWELL, K.A. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia. SCHIZOPHRENIA RESEARCH. ISSN 0920-9964, AUG 2015, vol. 166, no. 1-3, p. 212-218. [WOS]
    --- DAWSON, N. - KURIHARA, M. - THOMSON, D.M. - WINCHESTER, C.L. - MCVIE, A. - HEDDE, J.R. - RANDALL, A.D. - SHEN, S. - SEYMOUR, P.A. - HUGHES, Z.A. - DUNLOP, J. - BROWN, J.T. - BRANDON, N.J. - MORRIS, B.J. - PRATT, J.A. Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. TRANSLATIONAL PSYCHIATRY. ISSN 2158-3188, MAY 19 2015, vol. 5. [WOS]
    --- MIELNIK, C.A. - RAMSEY, A.J. Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia. DRUG DISCOVERY FOR SCHIZOPHRENIA. ISSN 2041-3203, 2015, no. 44, p. 115-140. [WOS]
    --- KRZYSTANEK, M. - BOGUS, K. - PALASZ, A. - KRZYSTANEK, E. - WORTHINGTON, J.J. - WIADERKIEWICZ, R. Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus. PHARMACOLOGICAL REPORTS. ISSN 1734-1140, 2015, vol. 67, no. 5, p. 965-969. [WOS]
    --- YAMAMOTO, H. - HAGINO, Y. - KASAI, S. - IKEDA, K. Specific Roles of NMDA Receptor Subunits in Mental Disorders. CURRENT MOLECULAR MEDICINE. ISSN 1566-5240, 2015, vol. 15, no. 3, p. 193-205. [WOS]
    --- OHGI, Y. - FUTAMURA, T. - HASHIMOTO, K. Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders. CURRENT MOLECULAR MEDICINE. ISSN 1566-5240, 2015, vol. 15, no. 3, p. 206-221. [WOS]
    --- HU, W. - MACDONALD, M.L. - ELSWICK, D.E. - SWEET, R.A. The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. YEAR IN NEUROLOGY AND PSYCHIATRY. ISSN 0077-8923, 2015, vol. 1338, p. 38-57. [WOS]
    --- VRAJOVA, M. - SCHUTOVA, B. - KLASCHKA, J. - STEPANKOVA, H. - RIPOVA, D. - SLAMBEROVA, R. Age-Related Differences in NMDA Receptor Subunits of Prenatally Methamphetamine-Exposed Male Rats. NEUROCHEMICAL RESEARCH. ISSN 0364-3190, NOV 2014, vol. 39, no. 11, p. 2040-2046. [WOS]
    --- PINACHO, R. - VALDIZAN, E.M. - PILAR-CUELLAR, F. - PRADES, R. - TARRAGO, T. - HARO, J.M. - FERRER, I. - RAMOS, B. Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia. JOURNAL OF PSYCHIATRIC RESEARCH. ISSN 0022-3956, NOV 2014, vol. 58, p. 189-196. [WOS]
    --- ZINK, M. - ENGLISCH, S. - SCHMITT, A. Antipsychotic treatment modulates glutamate transport and NMDA receptor expression. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. ISSN 0940-1334, NOV 2014, vol. 264, p. S67-S82. [WOS]
    --- GEDDES, A.E. - HUANG, X.F. - NEWELL, K.A. GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia. BMC PSYCHIATRY. ISSN 1471-244X, OCT 8 2014, vol. 14. [WOS]
    --- IASEVOLI, F. - TOMASETTI, C. - BUONAGURO, E.F. - DE BARTOLOMEIS, A. The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment. CURRENT NEUROPHARMACOLOGY. ISSN 1570-159X, 2014, vol. 12, no. 3, p. 219-238. [WOS]